These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2006-004950-25 WT1 TCR Gene Therapy for Leukaemia: A Phase I/II Safety and Toxicity Study 2018-04-17 due-trials
Exempt, with results 2011-001788-36 A Phase I/II study to investigate the safety of Adenovirus specific T cells given to high-risk paediatric patients post allogeneic haematopoietic stem cell transplant (allo-HSCT) to treat reactivation... 2016-12-31 not-yet-due
Reported results 2013-004380-31 A Phase 2 open label study to investigate the efficacy of autologous EBV-specific T-cells for the treatment of patients with aggressive extranodal NK/T-cell lymphoma (ENKTCL). 2018-09-05 due-trials
Reported results 2014-003111-10 A single arm Phase I/II study of the safety and efficacy of gene-modified WT1 TCR therapy in patients with myelodysplastic syndrome (MDS) or acute myeloid leukaemia (AML) who have failed to achieve or... 2018-05-15 due-trials